Side-by-Side Comparison
See how E8 Markets and Finotive Funding compare on profit split, challenge fee, drawdown rules, payout frequency, and verified trader ratings — all in one place.
Max Allocation
Trader Satisfaction
E8 Markets
Finotive Funding
Program name
Max allocation
Platforms
E8 Markets vs Finotive Funding
Program name
Account size
Steps
Profit split
Payout freq.
Price
Estimate your monthly take-home based on account size and expected monthly return.
Monthly Earnings
$6.4K
80% of $8K gross profit
80% Payout
Monthly Earnings
$6K
75% of $8K gross profit
75% Payout
Challenge information is currently unavailable for both E8 Markets and Finotive Funding, so a meaningful comparison cannot be made.
Challenge information is currently unavailable for both E8 Markets and Finotive Funding, so their pricing can't be compared.
Challenge information is currently unavailable for both E8 Markets and Finotive Funding, so their profit splits can't be compared.
E8 Markets offers a maximum allocation of $1,750,000, compared with Finotive Funding's $1,600,000. Traders looking to manage larger amounts of capital may prefer E8 Markets.
Challenge details for both E8 Markets and Finotive Funding are currently unavailable, so their evaluation processes can't be compared.
Challenge details are unavailable for both E8 Markets and Finotive Funding, so their drawdown rules can't be compared.
Challenge information is currently unavailable for both E8 Markets and Finotive Funding, so their payout schedules can't be compared.
Challenge information is currently unavailable for both E8 Markets and Finotive Funding, so their scaling plans can't be compared.
E8 Markets holds a 5 rating from 4 reviews, while Finotive Funding holds a 4.3 rating from 10 reviews. E8 Markets scores higher, but Finotive Funding's rating is based on a larger sample size, so both factors are worth considering.
200 Loyalty Points Welcome Bonus.
Sign up free to claim points, unlock rewards, save favorite firms, and start earning more through reviews and platform activity.